Devices and methods for prognosis prediction for melanoma cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9534258
SERIAL NO

14472755

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically, the invention relates to the use of genetic and protein markers for the prediction of the risk of progression of a cancer, such as melanoma, based on markers and signatures of markers. In various aspects, the invention provides methods, compositions, kits, and devices based on prognostic cancer markers, specifically melanoma prognostic markers, to aid in the prognosis and treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IVOCLAR VIVADENT AGBENDERERSTRASSE 2 SCHAAN FL-9494

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Black, Michael Alan Dunedin, NZ 6 48
Cebon, Jonathan Victoria, AU 13 63
Guilford, Parry John Dunedin, NZ 16 186
John, Thomas Victoria, AU 91 2331

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 3, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00